Csilla Sipeky

7.1k total citations
39 papers, 723 citations indexed

About

Csilla Sipeky is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Csilla Sipeky has authored 39 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Csilla Sipeky's work include Pharmacogenetics and Drug Metabolism (8 papers), Prostate Cancer Treatment and Research (8 papers) and Genetic Associations and Epidemiology (5 papers). Csilla Sipeky is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Prostate Cancer Treatment and Research (8 papers) and Genetic Associations and Epidemiology (5 papers). Csilla Sipeky collaborates with scholars based in Hungary, Finland and Belgium. Csilla Sipeky's co-authors include Béla Melegh, Luca Járomi, Veronika Csöngei, Enikő Sáfrány, Anita Maász, Katalin Horvatovich, Lili Magyari, Noémi Polgár, Johanna Schleutker and Bernadett Faragó and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Csilla Sipeky

36 papers receiving 708 citations

Peers

Countries citing papers authored by Csilla Sipeky

Since Specialization

Citations

This map shows the geographic impact of Csilla Sipeky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Csilla Sipeky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Csilla Sipeky more than expected).

Fields of papers citing papers by Csilla Sipeky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Csilla Sipeky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Csilla Sipeky. The network helps show where Csilla Sipeky may publish in the future.

Co-authorship network of co-authors of Csilla Sipeky

This figure shows the co-authorship network connecting the top 25 collaborators of Csilla Sipeky. A scholar is included among the top collaborators of Csilla Sipeky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Csilla Sipeky. Csilla Sipeky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree 2021 ·Cancers ·Lisa Cannon‐Albright, Craig C. Teerlink, Jeff Stevens, Franklin W. Huang, Csilla Sipeky, Johanna Schleutker, (unknown), Julio C. Facelli, Neeraj Agarwal, Donald L. Trump	5
2	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease 2021 ·Prostate Cancer and Prostatic Diseases ·Csilla Sipeky, Teuvo L.J. Tammela, Anssi Auvinen, Johanna Schleutker	8
3	ShAn: An easy-to-use tool for interactive and integrated variant annotation 2020 ·PLoS ONE ·Venkat Subramaniam Rathinakannan, (unknown), Samuel Heron, Johanna Schleutker, Csilla Sipeky	7
4	Prostate cancer risk prediction using a polygenic risk score 2020 ·Scientific Reports ·Csilla Sipeky, Kirsi Talala, Teuvo L.J. Tammela, Kimmo Taari, Anssi Auvinen, Johanna Schleutker	22
5	Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view 2019 ·The Pharmacogenomics Journal ·Réka Várnai, István Szabó, (unknown), (unknown), Attila Sı́k, Sándor Balogh, Csilla Sipeky	10
6	Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer 2018 ·Clinical Cancer Research ·Csilla Sipeky, Ping Gao, Qin Zhang, Liang Wang, Otto Ettala, Kirsi Talala, Teuvo L.J. Tammela, Anssi Auvinen, Fredrik Wiklund, Gong‐Hong Wei, Johanna Schleutker	21
7	Personalized laboratory medicine: a patient-centered future approach 2018 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Darko Černe, Irene Mancini, Lisa Simi, Mario Pazzagli, Chiara Di Resta, Helena Podgornik, Barbka Repič Lampret, Katarina Trebušak Podkrajšek, Csilla Sipeky, Ron van Schaik, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, (unknown)	29
8	CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in Hungary 2017 ·Environmental Toxicology and Pharmacology ·Réka Várnai, Csilla Sipeky, Lajos Nagy, Sándor Balogh, Béla Melegh	3
9	Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations 2015 ·BMC Genetics ·Ãgnes Nagy, Csilla Sipeky, (unknown), Béla Melegh, (unknown), (unknown), Kálmán Tóth	12
10	Interethnic variability of CYP4F2 (V433M) in admixed population of Roma and Hungarians 2015 ·Environmental Toxicology and Pharmacology ·Csilla Sipeky, (unknown), Béla Melegh, (unknown), (unknown), (unknown), István Szabó, Réka Várnai, (unknown), (unknown)	2
11	Increased prevalence of functional minor allele variants of drug metabolizing CYP2B6 and CYP2D6 genes in Roma population samples 2014 ·Pharmacological Reports ·(unknown), (unknown), Csilla Sipeky, Lili Magyari, (unknown), Luca Járomi, (unknown), (unknown), Erzsébet Kövesdi, Kinga Hadzsiev, Béla Melegh	13
12	High prevalence of CYP2C192 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature 2013 ·Molecular Biology Reports* ·Csilla Sipeky, (unknown), Melinda Zsuzsanna Szabó, Béla Melegh, (unknown), (unknown), István Szabó, Katalin Sümegi	17
13	Triglyceride Level-Influencing Functional Variants of the ANGPTL3, CILP2, and TRIB1 Loci in Ischemic Stroke 2011 ·NeuroMolecular Medicine ·Luca Járomi, Veronika Csöngei, Noémi Polgár, (unknown), Zoltán Szolnoki, Anita Maász, Katalin Horvatovich, Enikő Sáfrány, Csilla Sipeky, Lili Magyari, Béla Melegh	7
14	Genetic Variability and Haplotype Profile of MDR1 (ABCB1) in Roma and Hungarian Population Samples with a Review of the Literature 2010 ·Drug Metabolism and Pharmacokinetics ·Csilla Sipeky, Veronika Csöngei, Luca Járomi, Enikő Sáfrány, Anita Maász, István Takács, Judit Béres, Lajos Fodor, Melinda Zsuzsanna Szabó, Béla Melegh	31
15	Polymorphisms of the IL23R Gene Are Associated with Psoriasis but not with Immunoglobulin A Nephropathy in a Hungarian Population 2010 ·Inflammation ·Enikő Sáfrány, Márta Széll, Veronika Csöngei, Luca Járomi, Csilla Sipeky, (unknown), Lajos Kemény, Judit Nagy, Béla Melegh	22
16	Triglyceride level modifying functional variants of GALTN2 and MLXIPL in patients with ischaemic stroke 2010 ·European Journal of Neurology ·Noémi Polgár, Luca Járomi, Veronika Csöngei, Anita Maász, Csilla Sipeky, Enikő Sáfrány, Mihály Szabó, Béla Melegh	15
17	Variants of the IL23R Gene are Associated with Ankylosing Spondylitis but not with Sjögren Syndrome in Hungarian Population Samples 2009 ·Scandinavian Journal of Immunology ·Enikő Sáfrány, Borbála Pazár, Veronika Csöngei, Luca Járomi, Noémi Polgár, Csilla Sipeky, Ildikó Fanny Horváth, Margit Zeher, Gyula Poór, Béla Melegh	57
18	Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients 2009 ·Inflammation Research ·Enikő Sáfrány, (unknown), László Jakab, Tünde Tarr, Veronika Csöngei, Luca Járomi, Csilla Sipeky, (unknown), Margit Zeher, (unknown), László Czirják, Béla Melegh	18
19	Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome 2007 ·Pathology & Oncology Research ·Anita Maász, Péter Kisfali, Katalin Horvatovich, (unknown), Lajos Markó, Veronika Csöngei, Bernadett Faragó, Luca Járomi, Lili Magyari, Enikő Sáfrány, Csilla Sipeky, István Wittmann, Béla Melegh	50
20	Prevalence of SLC22A4 1672T and SLC22A5 −207C combination defined TC haplotype in Hungarian ulcerative colitis patients 2007 ·Pathology & Oncology Research ·Lili Magyari, Judit Bene, Katalin Komlósi, (unknown), Bernadett Faragó, Veronika Csöngei, Luca Járomi, Enikő Sáfrány, Csilla Sipeky, Lilla Lakner, Márta Varga, Beáta Gasztonyi, Béla Melegh	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact